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Table 1
metoprolol nebivalol carvedilol p
Male 38 (59.4%)a 21 (35%)b 32 (53.3%)a.b 0,02
Female 26 (40.6%)a 39 (65%)b 28 (46.7%)a.b 0.02
Diabetes
Mellitus
17 (26.6%) 20 (33.3%) 14 (23.3%) 0.494
Hypertension 51 (79.7%)a 33 (55%)b 36 (60%)b 0.008
Hyperlipidemia 29 (45.3%)a 9 (15%)b 14 (23.3%)b 0.001
Family History
of coronary
heart disease
9 (14.1%) 3 (5%) 5 (8.3%) 0.228
Smoking 29 (45.3%)a 14 (23.3%)b 25 (41.7%)a.b 0.023
Statin 33 (51.6%) 25 (41.7%) 28 (46.7%) 0.532
ACE 27 (42.2%) 16 (26.7%) 16 (26.7%) 0.114
ARB 18 (28.1%) 14 (23.3%) 16 (26.7%) 0.871
Tiazide 5 (7.8%) 6 (10%) 6 (10%) 0.902
Trimetazidin 3 (4.7%) 4 (6.7%) 3 (5%) 0.925
Metformine 10 (15.6%) 12 (20%) 7 (11.7%) 0.466
CIN 7 (10.9%) 5 (8.3%) 2 (3.3%) 0.283
Categorical distributions of various characteristics of the participants
Table 2
Metoprolol Nebivolol Carvedilol p
Age y 59.89.74a 58.2310.6a.b 54.5510.23b 0.014
BMI kg/m2 30.514.68 31.2814.18 29.934.77 0.711
EF % 58.149.88 60.459.96 57.7510.1 0.107
Mehran score 3.532.86 3.852.93 3.373.02 0.515
Total contrast
dose ml
127.9773.66a 99.6739.44a 104.6779.86b 0.009
Creatinine
clearance
89.1220.46 94.6425.98 96.6926.20 0.2
Basal
creatinine
0.890.21a 0.80.2b 0.80.16b 0.023
Second day
creatinine
0.920.26a 0.840.22a 0.820.17b 0.029
Fiﬁth day
creatinine
0.900.19a 0.810.20b 0.810.14b 0.008
HB 13.291.48 12.861.34 12.92.17 0.290
LDL 116.5434.5 115.5234.3 119.2141.1 0.855
TG 161.2389.2 168.27151.5 180.38122.3 0.753
Glukose 114.7237.3 118.9757.8 116.8753.9 0.652
Numerical data of the distribution of various characteritics of participants
Demographic charecteristics
Average age (years) 61,6 (36-85)
Diyabetes Mellitus (%) 56,0
Hyperlipidemia (%) 56,0
Cigarette (%) 37,8
Coronary Artery Disease (%) 87,8
Hypertension (%) 70,7
Gender (male %) 87,1
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Early and Midterm Outcomes of Percutaneous Treatment of Symtomatic
Stenosis of Lower Extremity and Chronic Limb Ischemia
Sakir Arslan, Isa Oner Yuksel, Erkan Koklu, Goksel Cagırcı, Selcuk Kucukseymen,
Nermin Bayar, Akar Yilmaz, Zehra Erkal, Cem Yunus Bas, Gorkem Kus, Murat Esin
Antalya Education and Research Hospital, Antalya
Objectıves: Our goal is to evaluate the effectiveness, reliability, advantages and the
results of early-to-mid-term of percutaneous treatment of lower extremity strictures.
Background: Technological advances in the past decade have shifted revasculari-
zation strategies from traditional open surgical approaches toward lower-morbidity
percutaneous endovascular treatments for patients with lower extremity peripheral
arterial disease (PAD). The role of endovascular interventions is also expanding in the
treatment of limb-threatening ischemia. Especially in chronic limb ischemia and foot
ulcers, diabetic patients with inoperable, there is growing interest below the knee
interventions.
Methods: Between May 2011 and May 2013, 85 patients with stenosis of the lower
limb arteries (iliac-femoral-popliteal-below the knee) and treated percutaneously,
enrolled in the study. Although medical therapy, patients with intermittent claudica-
tion and have >70% stenosis in iliac or femoral artery, stenting procedure was per-
formed after primary stenting or balloon angioplasty. Symptomatic patients withC224 JACC Vo>70% stenosis of popliteal or below-knee artery, balloon angioplasty was performed.
After the patients were followed up clinically.
Results: Tecnical success was achieved in 84 patients (98,8%). Predilatation before
stent placement, 33,3% of cases performed. Post dilation procedure was performed in
66,6% of patients with used the self-expanding stent. 84 patients with iliac-femoral
artery stenosis, stenting procedure is applied and concomitantly 6 patients with
popliteal artery and distal to the stenosis, the balloon angioplasty was performed.
Average follow-up time was 10,06,3 months. (1 – 25 Months). Including death,
myocardial infarction, major bleeding complications were not observed depending on
percutaneous procedures. Iliac stent in a patient as a complication inferior vena cava
ﬁstula formation, this complication was treated using a stent-graft. 7 patients with
diabetes and foot wounds that never heal, healed wounds were observed during
follow-up after the procedure. In the clinical follow-up, claudication complaints
decreased and increased walking distances observed.
Conclusıon: Technical success rate and early-midterm outcomes of percutaneous
treatment for PAD are magniﬁcent. We believe that percutaneous treatment methods
in lower extremity arterial stenosis, will be more widespread with percutaneous
treatment techniques and operator experience increases.PP-361
Percutaneous Closure of Patent Ductus Arteriosus: Experience of a Tertiary
Referral Center
Hasan Kaya, Faruk Ertas¸, Nihat Polat, Abdulkadir Yıldız, Mehmet Ata Akıl,
Mehmet Serdar Soydinç, Sait Alan, Mehmet Sıddık Ülgen
Department of Cardiology, Dicle University Faculty of Medicine, Diyarbakır
Objectıve: We sought to evaluate our clinical experience and short-term results of
percutaneous closure of patent ductus arteriosus (PDA).
Materıals-Methods: We studied 20 patients (17 female, mean age 248 years)
undergoing percutaneous closure of PDA between March 2010-March 2013 in our
clinic. Amplatzer duct occluder (ADO) I was used in 13 patients and ADO II was used
in 7 patients for PDA closure. Clinical charecteristics of patients, properties of
percutaneous closure intervention, complications and short-term results are evaluated.
Results: The mean ductus waist diameter measured by angiographic examination was
52 mm (2-9 mm). Procedure was successfully performed in all patients. Occluder
device embolization was occurred in one patient in whom device was retrieved by
snare catheter and PDA was successfully closed with same device. The early total
occlusion rate was 85%. Occlusion rate as determined by echocardiographic control
performed the day after was 95% whereas 100% at ﬁrst month. In the follow-up of
199 months, no complications were observed.
Conclusıon: Percutaneous closure of PDA using ADO I and II devices are safe and
effective.
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Comparison of Clinical and Angiographic Parameters Right Coronary Artery
Shapes in Patients With Acute Myocardial Infarction from Right Coronary
Artery
Mehmet Sait Altıntas¸1, Necip Ermis¸1, Bilal Çuglan2, Erdal Altürk3,
Ramazan Özdemir1
1Inonu University, School of Medicine, Department of Cardiology, Malatya, 2Malatya
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Purpose: Atherosclerosis is associated with the hemodynamic factors emerged from
the geometry of vessels outside of the traditional risk factors. When compared C and S
(sigma) shape of right coronary artery (RCA), C shape was found to be more asso-
ciated with coronary artery disease in previous studies. However, in patients admitted
with acute myocardial infarction(AMI) from the RCA, the effect of these two
geometric shape of RCA did not evaluated on TIMI frame count (TFC), distribution
and length of the lesion. The aim this study was to compare intracoronary ﬂow rates,
localization and severity of lesion between C and S shapes of RCA on coronary
angiography images by evaluation of angiographic images of primary percutaneous
interventions in AMI which is caused by RCA in our center.
Methods: The angiographic images of 163 of patients were evaluated who performed
primary percutaneous intervention due to AMI from RCA. Patients were divided into
two groups according to the geometric shape of RCA. Clinical and angiographic
parameters were compared in terms of C and S shapes of RCA.l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
Results: There was no statistical difference between two groups in terms of demo-
graphic characteristicts even the age was higher in C-shape (Table 1). In C-shape
patients, the frequency of proximal and mid region lesions were found more than
distal lesions (p¼0.014) but there was no differences in S-shape patients. TFC in
patient group with S-shape were signiﬁcantly higher than patient group with C shape
when both groups were compared in terms of TFCs. The two groups lesion regions
were compared each other and there were no difference between vascular diameters.
Conclusıons: The frequency of lesion was higher in the proximal and mid sections of
C shape RCA. TFCs were signiﬁcantly higher in patients with S-shape group than
patients C shape group when they were compared in terms of TFCs.Demographics Parameters
C-shape (n¼124) S-shape (n¼39) P count
Age (years) 66,1512,28 59,9810,82 0,003
Diabetesmellitus 31(% 25) 12(% 30,8) 0,476
Hyperlipidemia 29(% 23,4) 8(% 20,5) 0,709
Smoking 34(% 27,4) 12(% 30,8) 0,685
The comparison of baseline characteristics of the patient groups.
Variables
GFRlowgroup (n ¼
205)
GFRhighgroup (n
¼ 206) P value
DM, n (%) 120 (58.5%) 34 (16.5%) <0.001
HT, n (%) 117 (57.1%) 78 (37.9%) <0.001
Creatinine (mg/dl) 1.050.21 0.720.13 <0.001
SYNTAX Score 17.99.7 8.25.1 <0.001
AD 2.01.1 2.81.6 <0.001
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The Effects of Stent Postdilatation on Angiographic and Clinical Outcomes in
Patients with ST-Elevation Myocardial Infarction
Kanber Ocal Karabay1, Emine Altuntas1, Serkan Kahraman1, Ersin Ozen2,
Onder Demıroz1, Omer Yildiz2, Vedat Aytekin2
1Istanbul Bilim University, Istanbul, 2Sisli Florence Nightingale Hospital, Istanbul
Background: Postdilatation after stent implantation in stable patients has been re-
commended to achieve better angiographic results, but its effect in primary percuta-
neous coronary intervention (PCI) is less clear.
Objective: Our objective was to determine whether postdilatation has an effect on
clinical outcomes in STEMI. Our objective was to determine whether postdilatation
has an effect on clinical outcomes in STEMI.
Methods: This study was a single-center retrospective, observational study including
patients who presented with STEMI and were treated with primary PCI between
January 2008 and March 2013. Patients with STEMI who were treated with primary
PCI were included. Patients with non-ST-elevation myocardial infarction, bypass graft
occlusion, or who were not treated with primary PCI were excluded. The patients were
divided into two groups: 1) patients who did not undergo postdilatation after stent
implantation (Group 1) and 2) patients who underwent postdilatation (Group 2). The
patient demographics, risk factors, clinical presentation, procedural properties, and
major adverse cardiac events (MACE), including target lesion revascularization, target
vessel failure, and cardiac death at the hospital or during follow-up, were compared
between the two groups.
Conclusıon: In total, 227 patients underwent primary PCI for STEMI and were treated
with at least one stent. A total of 218 patients were included (Group 1¼ 57, Group
2 ¼161). The follow-up time was 79.68 58.89 weeks in Group 1 and 141.30 
87.07 weeks in Group 2 (p<0.001). The patient demographics, risk factors, clinical
presentation and procedural properties were all similar except for the increased use of
predilatation (75.4% vs. 94.4%, p<0.001) and intracoronary nitroglycerine in Group 2
(50.9% vs. 71.4%, p<0.05). The mean ﬁnal TIMI coronary ﬂow was better in Group 1
(2.89  0.31 vs. 2.61  0.66, p<0.05). The MACE rate both in hospital and during
follow-up did not differ between Groups 1 and 2.
Conclusion: Although stent postdilatation is negatively correlated with the ﬁnal TIMI
ﬂow grade, it does not appear to be correlated with worse long-term clinical outcomes.
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Impaired Kidney Function Associated with Both Syntax Score and Aortic
Distensibility in Patients with Stable Coronary Artery Disease
Hakan Uçar, Mustafa Gür, Taner S¸eker, Durmus¸ Yıldıray S¸ahin, Gökhan Gözübüyük,
Caner Türkoglu, Arafat Yıldırım, Onur Kaypaklı, Zafer Elbasan, Murat Çaylı
Adana Numune Training and Research Hospital, Department of Cardiology
Background: The strong relationships between severe renal dysfunction with coro-
nary artery disease (CAD) and arterial stiffness are well known. However, the asso-
ciations between the kidney function with SYNTAX Score and aortic distensibility
(AD) were not investigated in patients with stable CAD with normal to mildly
impaired renal function. We aimed to investigate the association between kidney
function with SYNTAX score and AD.
Methods: In this study, 411 stable CAD patients in whom coronary angiography was
performed were prospectively included (247 male, 164 female; mean age 58.612.4
years). GFR was estimated (eGFR) by the Modiﬁcation of Diet in Renal Disease
formula. Two different groups were determined according to median eGFR values
(GFRlow group <100.6, and GRFhigh group 100.6). Coronary angiography was
performed based on clinical indications. SS was determined in all patients. AD was
calculated from the echocardiographicallyJACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTResults: Patients with GFRlow group were older, and have a history of hypertension
and diabetes mellitus and high BMI. SS and AD values of GFRlow group were
higher than GFRhigh group (p<0.001 for all). Multivariate regression analysis
showed that eGFR was independently associated with diabetes (b;-0.206, p<0.001),
hypertension (b;-0.093, p¼0.026), SS (b;-0.445, p<0.001) and AD (b;-0.096,
p¼0.019).
Conclusıon: Estimated GFR is independently associated with extent and complexity
of CAD and AD as well as frequencies of diabetes and hypertension. Importantly,
these results may explain, in part, the increase in cardiovascular risk in with slightly
impaired renal function.PP-365
Evaluation of Platelet to Lymphocyte Ratio to Predict No-Reﬂow in Patients
With Acute Myocardial Infarction
Abdulkadir Yıldız1, Abdullah Tuncez2, Nihat Polat1, Halit Acet1, Mustafa Oylumlu1,
Murat Yuksel1, Abdurrahman Akyuz1, Mesut Aydin1, Mehmet Zihni Bilik1,
Mehmet Ata Akil1, Faruk Ertas1, Hasan Kaya1, Mehmet Ali Elbey1
1Dicle Universty School of Medicine, Department of Cardiology, Diyarbakir, 2Konya
Numune Hospital, Department of Cardiology, Konya
Aım: The platelet to lymphocyte ratio (PLR) has been shown as a predictor in
patients with malignancies but little is known about the association between PLR
and adverse events in the setting of acute ST-segment elevation myocardial
infarction (STEMI) treated with primary percutaneous intervention (PCI). Thus, we
sought to assess the predictive value of pre-procedural PLR on the development of
no-reﬂow in patients undergoing coronary stent implantation for the treatment of
STEMI.
Methods: Thrombolysis In Myocardial Infarction (TIMI) ﬂow grades of 287 patients
with STEMI treated with primary PCI were assessed. No-reﬂow was deﬁned as TIMI
Grade 2 ﬂows and angiographic success was deﬁned as TIMI 3 ﬂow.
Results: Patients were divided into 3 tertiles based upon pre-procedural PLR. No-
reﬂow developed in 6,14 and 43 patients in lower, middle and higher tertiles,
respectively (p< 0.001). Pre-procedural PLR was signiﬁcantly correlated with the
neutrophil/lymphocyte ratio (NLR) and age (r:0.697, p<0.001 and r:0.191,
p¼0.001;respectively). After regression analysis, pre-procedural PLR remained as
a signiﬁcant predictor of stent thrombosis (OR: 1.010, 95% conﬁdence interval: 1.004-
1.017, p¼0.001) together with pre-procedural NLR (OR: 1.200, 95% conﬁdence
interval: 1.059-1.360, p¼0.004). In receiver operating characteristics analysis, the
PLR> 160 had 75% sensitivity and 74% speciﬁcity and the NLR> 5.9 had 71%
sensitivity and 70% speciﬁcity in predicting no-reﬂow.
Conclusıon: High pre-procedural PLR is a signiﬁcant and independent predictor of
no-reﬂow in patients with acute STEMI undergoing primary PCI.ERS C225
